Diabetic Macular Edema (DME) Terminated Phase 1 Trials for Lifitegrast (DB11611)

Also known as: Diabetic Macular Edema(DME) / Diabetic Macular Oedema / Macular Edema, Diabetic / Diabetic Macular Edema / Macular edema due to diabetes mellitus (disorder) / Diabetic retinal oedema / Diabetic retinal edema

IndicationStatusPhase
DBCOND0060562 (Diabetic Macular Edema (DME))Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00936520SAR 1118 in Human Subjects Undergoing Pars Plana VitrectomyTreatment